Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomas Baka

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Therapeutic Advances in Chronic Disease|April 25, 2022
Chronotherapy of cardiovascular pathologies: a hopeful strategyFedor Simko, Tomas Baka
Frontiers in Pharmacology|February 14, 2022
Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial CellsFedor Simko, Tomas Baka
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 21, 2024
Pharmacological stimulation of the parasympathetic system - a promising means of cardioprotection in heart failureFedor Simko, Tomas Baka
Medical Hypotheses|August 3, 2019
Ivabradine modulates the autonomic nervous system by affecting the "little brain" of the heart: A hypothesisTomas Baka, Fedor Simko
Clinical and Experimental Pharmacology & Physiology|February 22, 2019
Ivabradine reversed nondipping heart rate in rats with l-NAME-induced hypertensionTomas Baka, Fedor Simko
British Journal of Clinical Pharmacology|June 22, 2019
Chronotherapy as a potential approach to hypertensive patients with elevated heart rate?Fedor Simko, Tomas Baka
Frontiers in Cardiovascular Medicine|March 1, 2021
Ivabradine and Blood Pressure Reduction: Underlying Pleiotropic Mechanisms and Clinical ImplicationsFedor Simko, Tomas Baka
Autonomic Neuroscience : Basic & Clinical|February 13, 2018
Nondipping heart rate: A neglected cardiovascular risk factor based on autonomic imbalance?Tomas Baka, Fedor Simko
Clinical Science (London, England : 1979)|April 21, 2021
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat?Fedor Simko, Tomas Baka
Frontiers in Cardiovascular Medicine|August 9, 2021
Monitoring Non-dipping Heart Rate by Consumer-Grade Wrist-Worn Devices: An Avenue for Cardiovascular Risk Assessment in HypertensionTomas Baka, Fedor Simko
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Therapeutic Advances in Chronic Disease|April 25, 2022
Chronotherapy of cardiovascular pathologies: a hopeful strategyFedor Simko, Tomas Baka
Frontiers in Pharmacology|February 14, 2022
Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial CellsFedor Simko, Tomas Baka
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 21, 2024
Pharmacological stimulation of the parasympathetic system - a promising means of cardioprotection in heart failureFedor Simko, Tomas Baka
Medical Hypotheses|August 3, 2019
Ivabradine modulates the autonomic nervous system by affecting the "little brain" of the heart: A hypothesisTomas Baka, Fedor Simko
Clinical and Experimental Pharmacology & Physiology|February 22, 2019
Ivabradine reversed nondipping heart rate in rats with l-NAME-induced hypertensionTomas Baka, Fedor Simko
British Journal of Clinical Pharmacology|June 22, 2019
Chronotherapy as a potential approach to hypertensive patients with elevated heart rate?Fedor Simko, Tomas Baka
Frontiers in Cardiovascular Medicine|March 1, 2021
Ivabradine and Blood Pressure Reduction: Underlying Pleiotropic Mechanisms and Clinical ImplicationsFedor Simko, Tomas Baka
Autonomic Neuroscience : Basic & Clinical|February 13, 2018
Nondipping heart rate: A neglected cardiovascular risk factor based on autonomic imbalance?Tomas Baka, Fedor Simko
Clinical Science (London, England : 1979)|April 21, 2021
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat?Fedor Simko, Tomas Baka
Frontiers in Cardiovascular Medicine|August 9, 2021
Monitoring Non-dipping Heart Rate by Consumer-Grade Wrist-Worn Devices: An Avenue for Cardiovascular Risk Assessment in HypertensionTomas Baka, Fedor Simko
Pageof 4